Altered strategy in the treatment of patients with recurrent ovarian cancer. According to the proceedings of the 5th International Conference on Gynecologic Oncology hosted by the MD Anderson Cancer Center (Madrid, Spain, 24–26 February 2016)
The paper highlights main areas in the development of European oncology care to patients with malignant ovarian neoplasms. It discusses the major issues considered at the 5th Annual Meeting of Oncologists on Arrangement of Anticancer Therapy into the Era of Personalized Therapy hosted by the MD Ande...
Main Author: | A. G. Kedrova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2016-06-01
|
Series: | Opuholi Ženskoj Reproduktivnoj Sistemy |
Subjects: | |
Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/479 |
Similar Items
-
Translation and validation of the Chinese version of the MD Anderson symptom inventory for measuring perioperative symptom burden in patients with gynecologic cancer
by: Ting Zhang, et al.
Published: (2021-07-01) -
Integrative Medicine Program- MD Anderson Cancer Center
by: Richard T Lee
Published: (2012-06-01) -
Evaluation of the psychometric properties and minimally important difference of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM)
by: Tito R. Mendoza, et al.
Published: (2019-06-01) -
Significance of Malignant Peritoneal Cytology on the Survival of Women with Early-Stage Cervical Cancer: A Japanese Gynecologic Oncology Group Study
by: Koji Matsuo, et al.
Published: (2019-11-01) -
Portuguese validation of the Symptom Inventory of the M.D. Anderson Cancer Center
by: Adriane Cristina Bernat Kolankiewicz, et al.
Published: (2014-12-01)